Vext Science, Inc. (OTCQX: VEXTF) (CSE:VEXT) revenue in the Q3 2022 was $7.7 million, a decrease of 18% compared to $9.4 million in Q3 2021, and a decrease of 12% compared to 8.8 million in Q2 2022.

Eric Offenberger, CEO of …

Full story available on Benzinga.com